BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Through many years of neglect\, the field of women's health ha s long been under researched and underfunded\, resulting in the misdiagno sis and mistreatment of females across the world. From invasive diagnosti c measures for endometriosis cases to outdated clinical techniques to det ermine an imbalance in vaginal microbiota\, women have long felt under-re presented across the health care system regarding indications of the repr oductive system.\n\nA combination of shared frustration and collaborative passion from industry pioneers has reignited the momentum across the fie ld\, shifting the investment spotlight to shine bright on women's health biotech and pharma. 2024 has already witnessed Freya Bioscience raising $ 38 million for microbial immunotherapies\, as well as Heranova Lifescienc es debuting $13.5 million in seed funding for clinical solutions across w omen's health. The time is now for the community to unite and drive clini cal progress across women's health\, paving the way for an increase in ma rket access and hope for millions of women currently suffering across the globe.\n\nThe Women's Health Therapeutics and Diagnostics Summit present s the ultimate platform to combine forces across biotech and biopharma\, showcasing the industry trailblazers to drive innovation and clinical pro gress across a range of disease indications. From endometriosis to bacter ial vaginosis to infertility\, pre-term birth\, menopause and more\, the need for in-depth conversations surrounding current standard of care\, te chnological advancements and innovative pipeline developments has never b een higher.\n\nIt is now imperative for industry to unite\, with the like s of Ferring Pharmaceuticals\, Organon\, Hera Biotech\, Evvy\, Gynica\, F reya Bioscience and more sharing case studies and data-driven insights\, bringing the latest technological developments to the fore and overcoming the current translational challenges. A collective goal of propelling no vel treatments and diagnostic tools to market in both a safe and efficaci ous manner remains pivotal\, striving towards a personalized medicines ap proach.\n\nRemain central to the conversation and hear from the world lea ders in the field as 60+ women's health leads\, clinical heads and expert s from biotech and biopharma touch down in Boston to continue the revolut ion.\n\nFor more details about the program\, speaker faculty or pricing a nd discounts\, download the brochure.\n\nURLs:Brochure: \;https://go. evvnt.com/2341040-0?pid=185Tickets: \;https://go.evvnt.com/2341040-2? pid=185\n\nPrices:Conference + 2 Workshops - Industry Pricing: USD 4197.0 0\,Conference + 1 Workshop - Industry Pricing: USD 3598.00\,Conference On ly - Industry Pricing: USD 2999.00\,Conference + 2 Workshops - Discounted Pricing: USD 3597.00\,Conference + 1 Workshop - Discounted Pricing: USD 3098.00\,Conference Only - Discounted Pricing: USD 2599.00\,Conference + 2 Workshops - Vendor Pricing: USD 5097.00\,Conference + 1 Workshop - Vend or Pricing: USD 4398.00\,Conference Only - Vendor Pricing: USD 3699.00\n\ nSpeakers: \;Shelley Amster\, Co-Founder\, Chief Strategy and Growth Officer\, 3Daughters\, Paul Korner\, Chief Medical Officer\, Agile Therap eutics\, Jennifer Garrison\, Assistant Professor\, Buck Institute for Res earch on Aging\, Stephen Palmer\, Chief Scientific Officer\, Celmatix\, J ared Kehe\,Co-founder and Chief Scientific Officer\, Concerto Biociences\ , Roger Frechette\, Chief Business Officer\, Concerto Biociences\, David Friend\, Chief Scientific Officer\, Dare Bioscience\, Pita Navarro\, Chie f Scientific Officer\, Evvy\, Katie Barletta\, Medical Director US RandD\ , Ferring Pharmaceuticals\, Johan E.T. van Hylckama Vlieg\, Chief Sceinti fic Officer and Co-Founder\, Freya Biosciences\, Yotam Hod\, CEO and Co-F ounder\, Gynica\, Cinzia Donato\, Chief Operating Officer\, Hera Biotech\ , Farideh Bischoff\, Chief Medical Officer\, Heranova Lifesciences\, Nata lie Getreu\, Co-Founder and Chief Operating Officer\, Hertility Health\, Ridhi Tariyal\, Chief Executive Officer and Co-Founder\, Next Gen Jane\, Edith Roset Bahmanyar\, Executive Director Clinical Research\, Organon\, Denise Kelly\, Investment Advisor\, Seventure\, Mark Connell\, Chief Oper ating Officer\, SLBST Pharma\n\nCategory: \;Conferences | Science\, H ealth and Medicine | Pharmaceuticals\n\nDate and Time: \;23rd July 20 24 at 9:00 am to 25th July 2024 at 5:00 pm\n DTEND:20240725T170000 DTSTAMP:20260512T220332Z DTSTART:20240723T090000 LOCATION:Hilton Boston Back Bay\, 40\, Dalton Street\, Boston\, Massachuse tts\, 02115\, SEQUENCE:0 SUMMARY:Through many years of neglect\, the field of women's health has lo ng been under researched and underfunded\, resulting in the misdiagnosis and mistre... UID:c96871df-7f24-488b-952b-093ecc1dc507 END:VEVENT END:VCALENDAR